Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Human Papillomavirus Recombinant Vaccine nonavalent × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Papillomavirus Infections 6 Acquired Immunodeficiency Syndrome 2 Warts 1 Uterine Cervical Dysplasia 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myeloid, Acute 1 Human Papillomavirus-Related Cervical Carcinoma 1 Human Papillomavirus-Related Carcinoma 1 Hematologic Neoplasms 1 HIV Infections 1 Condylomata Acuminata 1

Interventions

pembrolizumab 76 Blood Specimen Collection 37 Cyclophosphamide 33 Nivolumab 32 Bevacizumab 31 Standard of Care 30 Carboplatin 29 Paclitaxel 26 Surveys and Questionnaires 25 atezolizumab 23 Pemetrexed 21 Fluorouracil 21 Radiotherapy 20 Leucovorin 20 Docetaxel 20 Dexamethasone 20 Oxaliplatin 19 Cisplatin 19 Gemcitabine 17 Exercise 17 Irinotecan 15 fludarabine 14 Interviews as Topic 14 dostarlimab 13 Drug Therapy 13 Cetuximab 13 Capecitabine 13 Rituximab 12 durvalumab 11 Trastuzumab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06658405 2026-03-18

HPV2

Centre Oscar Lambret

Phase 2 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡